Biophile is a mission-driven bioeconomy Intangible Asset company, created to maximise IA value for bioeconomy startups. We have created value uplifts of more than $500M for startups and research groups since 2021.

​​

Our clients reflect our values: adventurous, original innovators that want to change the world with their life-enhancing technologies. All while having fun and enjoying the journey!

​​​

Our mission is to help as many biosciences, especially bioeconomy, products as possible get to market by making them as investable as possible, creating compelling IP narratives, and introducing these technologies and teams to funders.

​

We work with two types of teams: cutting-edge research organisations and young, audacious bioscience leaders that want to expand their impact on a global scale. We provide on-demand technology transfer and IP management services. This is backed up by deep experience in aligning efforts within and outside of client organisations by creating IP policies and strategies that reflect the complexities of the world they inhabit. 

​​​

We are proud of the fact that we were the first IP-centric strategy company in the world focused only on biosciences. We rely heavily on devising cutting edge, intangible assets strategies to give our clients an invisible edge and then back this up with world-class advice.